mots c 5 amino 1mq 5-Amino-1MQ/NAD/MOTS-C Atomizer NAD+ / MOTS-C / 5-Amino-1MQ
Description
Stop using it
The relationship between body weight and optimal dosing has not been established through controlled trials
UK patients should consult their GP and report any suspected adverse effects to the MHRA via the Yellow Card Scheme
The follow-up that matters for this specific compound landed in 2018, when a small-molecule NNMT inhibitor was given to obese mice
Core Molecule: 5-amino-1-methylquinolin-1-ium Format: Oral Tablets Mechanism: Selective Nicotinamide N-methyltransferase (NNMT) Inhibitor Purity: 98% (HPLC) Salt Form: Iodide or Chloride
The blend is offered for research examining these together
